CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on October 15, 2008
Clinical Journal of the American Society of Nephrology
© 2008 American Society of Nephrology
doi: 10.2215/CJN.00900208
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.00900208v1
3/6/1800    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrade, J.
Right arrow Articles by Levin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrade, J.
Right arrow Articles by Levin, A.

Received February 23, 2008
Accepted on July 24, 2008

ORIGINAL ARTICLES

Exploration of Association of 1,25-OH2D3 with Augmentation Index, a Composite Measure of Arterial Stiffness

Jason Andrade *{dagger}, Lee Er {ddagger}{sect}, Andrew Ignaszewski *{dagger}, and Adeera Levin *{sect}||1

*Department of Medicine, {dagger}Division of Cardiology, {ddagger}Centre for Health Evaluation and Outcome Sciences, {sect}BC Provincial Renal Agency, and ||Division of Nephrology, University of British Columbia, St. Paul’s Hospital, Vancouver, British Columbia, Canada


1 To whom correspondence should be addressed. E-mail: alevin{at}providencehealth.bc.ca.


   Abstract

Background and objectives: Abnormalities in mineral metabolism [calcium, phosphate, and immunoreactive parathyroid hormone (PTH)] and vitamin D have been linked to increases in central arterial stiffness. Central arterial stiffness can be measured using noninvasive technologies, including augmentation index (AIx), a composite measure of arterial stiffness.

Design, setting, participants, and measurements: In 131 outpatients identified from individual cardiac or kidney disease clinics, we examined conventional demographic and laboratory risk factors, vitamin D levels (1,25-OH2D3 and 25-OHD3), and markers of inflammation or endothelial function [C-reactive peptide (hsCRP), matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase 9 (MMP-9), and IL-6] in relationship to AIx.

Results: The median eGFR was significantly different between clinics (range 25–81 ml/min). Subjects with higher phosphate or MMP-9 levels were found to have a higher AIx (P = 0.02 and 0.07, respectively). Lower 1,25-OH2D3 levels or reduced eGFR were associated with higher AIx (P = 0.002 and 0.005, respectively). The associations between 1,25-OH2D3 and phosphate levels and AIx were observed for values within the normal range. No association was noted for calcium, iPTH, 25-OHD3, or hsCRP and AIx. Adjusting for potential confounders [eGFR, calcium, phosphate, and (log) iPTH] the association of lower 1,25-OH2D3 with AIx remained statistically significant.

Conclusion: This exploratory study demonstrates a significant association between AIx and 1,25-OH2D3 in a diverse group with cardiac, kidney disease, or both. These increasing understanding of the role of vitamin D in vascular health lends a context to these findings and raises questions as to additional modifiable risk factors in complex patients. Further studies are required.




This article has been cited by other articles:


Home page
CJASNHome page
M. Johal and A. Levin
Vitamin D and Parathyroid Hormone in General Populations: Understandings in 2009 and Applications to Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. W.Y. Chung, H.H. C. Yang, M. K. Sigrist, G. Brin, E. Chum, W. A. Gourlay, and A. Levin
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease
Cardiovasc Res, August 3, 2009; (2009) cvp242v2.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Society of Nephrology.